Industry Policy Committee Disease awareness/education/information for patients

As of August 8, 2024

Company name Activities being undertaken in relation to intractable and rare diseases
Astellas Pharma Inc. Astellas is conducting research and development for the practical application of cellular medicine and gene therapy, which are new therapeutic tools that directly address the underlying causes of disease for diseases for which there is still no effective treatment.
Astellas Open Forums are held for the general public to provide easy-to-understand explanations of cell medicine and gene therapy, as well as opportunities to engage in dialogue with patient groups and other stakeholders in the fields of intractable and rare diseases.
First Forum (October 2021): New Treatment Options for Patients: Evolving Regenerative and Cellular Medicine
2nd Forum (March 2022): New Treatment Options for Patients: How Cell Medicine Reaches Patients
3rd Forum (July 2022): New Treatment Options for Patients: Listening to the Voices of People Living with Intractable Diseases
4th Forum (November 2022): New Treatment Options for Patients: Understanding the Potential of Gene Therapy
5th Forum (April 2023): New Treatment Options for Patients: Challenges and Solutions for Realizing World-Leading Medical Care in Japan
Eisai
The company offers a paper-based symptom identification notebook that incorporates the opinions of Parkinson's disease patients and physicians. In addition, the following information is provided on the "Parkinson's Disease Symptoms and Progression (PD Net)*" website
(1) Learn about the disease
2) Public support system
(3) Treatment and medications
(4) How to live with Parkinson's disease
(5) Patients' voices
This website supports patients' treatment by providing videos of rehabilitation and a downloadable "Symptom Notebook".
h ttps:// pdnet.eisai.jp
Kissei Pharmaceutical Co. ■Disease awareness activities for patients/families through the disease information website "ANCA-related Vasculitis for Patients
We have launched a website to make families of patients with ANCA-related vasculitis, for whom early diagnosis and early treatment are important for prognosis, aware of the possibility of this disease and to support them in receiving appropriate diagnosis and treatment, and are operating the website through posting the following contents.
Provides correct information on ANCA-related vasculitis based on the supervision of medical specialists and interviews with medical specialists.
Patient testimonials are posted on the site.
To help patients/families find reliable medical institutions more smoothly, the site introduces specialized medical institutions and departments that can provide treatment through the "Ishamachi Hospital Search Service".
Kyowa Kirin Co. Deepening disease awareness activities for patients/families through the disease information website "Kurukotsu Hiroba
We have launched a website "Kurutsubu Hiroba" to help undiagnosed rickets/osteomalacia patients and their families become aware of the possibility of this disease and receive appropriate diagnosis/treatment, and are operating the site by posting the following contents.
Providing correct information on rickets/osteomalacia under the supervision of medical specialists and posting interviews with medical specialists
Explanation of the medical subsidy system related to FGF23-related hypophosphatemic rickets/osteomalacia
Introduction of specialized medical institutions with experience in medical care through the "Ishamachi Hospital Search Service" so that patients/families can more smoothly find reliable medical institutions.
Patient stories" based on interviews with patients suffering from the disease
Establishment of "Patient-to-Patient Exchange" content for patients who have been diagnosed.
Since no patient associations exist, in addition to disseminating information and reports on public lectures jointly held by ASrid (Japanese name: ASrid)/Kyowa Kirin, a specified nonprofit corporation, we provide a place where patients can interact with each other. In addition, a "telephone consultation room" has been established as a new content in Kurukotsu Hiroba to listen to the concerns of patients through two-way communication by telephone with medical professionals, to make it easier to receive necessary information for individual patients, and to help patients who suspect a disease to connect with a medical specialist. We also help patients who suspect a disease to connect with a specialist.
Public Lectures
Since there are no patient associations for rickets/osteomalacia, we continue to provide information to patients and their families by holding public lectures co-hosted by ASrid/Kyowa Kirin, a non-profit organization, showing videos of patients' appearances and providing medical information.
Sanofi <Public Lectures
■Sanofi periodically holds "web-based public lectures" for patients and patients' families. In the lectures, patients share their own ideas and wisdom in daily life, and specialists provide information on government systems and other services with the aim of improving the quality of life of patients and those around them.
TETOTE no madoguchi", website "LISOLIFE", material delivery service
Access to correct information for patients and their families is important for better medical care.
The "TETOTE no Madoguchi" service provides patients and their families with answers to their questions and concerns via telephone or e-mail by dedicated staff. The website "Lysolife" provides a variety of information useful for medical treatment, and support materials for patients and their families can be delivered by mail.
Teto Tete no Madoguchi (Teto Tete Window)
Lysosomal disease website, Lysolife (lysolife.jp)
Web site "Lysolife
Information site on symptoms and treatment of lysosomal disease Lysolife (lysolife.jp)
URL: https: //www.lysolife.jp/
Shionogi Shionogi introduces information on symptoms and treatments for idiopathic pulmonary fibrosis (IPF) and lipoatrophy, which are intractable and rare diseases, on its website.
Idiopathic pulmonary fibrosis (IPF): http://www.shionogi.co.jp/IPF/
Lipoatrophy: https://wellness.shionogi.co.jp/shibouisyuku/patient.html
Sumitomo Pharma
We have established "Rehabilitation Kitchen for Parkinson's Disease Patients" and "Fabry's Disease Plaza" on our health information website for patients and the general public.
(1) Rehabilitation with the theme of cooking that can be done at home is introduced. The concept is that cooking while being aware of each movement will lead to rehabilitation for Parkinson's disease patients.
We also provide a downloadable symptom diary that allows patients to take notes on their daily symptoms and medications.
(2) Based on the contents of the "Fabry's Disease Handbook" prepared for patients, the handbook provides easy-to-understand information on the pathogenesis of Fabry's disease and the precautions to take in daily life.
Takeda Pharmaceutical Company Limited Initiatives related to Rare Disease Day
We have been continuously sponsoring Rare Disease Day ("RDD") since 2014 in the hope of raising awareness and promoting understanding of this rare and intractable disease. In addition, the RDD Symposium is held in conjunction with RDD every February. The purpose of this symposium is to increase awareness of rare diseases, expand the circle of support for patients, and create a society that is easier to live in. The previous symposium was held in February 2024 under the theme of "Let's All Know and Communicate Rare Genetic Diseases Correctly.
 
Symbiosis Canvas
Every year, our employees conduct in-person or online classes on intractable and rare diseases for junior high school students nationwide (about 10 schools) with the aim of "encouraging them to think about creating a society in which all people can shine together, using issues related to rare and intractable diseases as a starting point. Through these activities, we believe we can contribute to the creation of a healthy society and a society in which all people can shine together.
 
IBDream Confectionery Pictorial Book】 【IBDream Confectionery Pictorial Book
As part of the "IBDream Project" activities to address the concerns of inflammatory bowel disease (IBD) patients and work with various companies and organizations to find solutions, we have released the "IBDream Confectionery Pictorial Book" to support IBD patients in selecting confectionery, with the cooperation of eight confectionery companies.
Mitsubishi Tanabe Pharma Corporation
  • Mitsubishi Tanabe Pharma Corporation shared public information on clinical trials with patient groups, which then selected the information and passed it on to patients and others. The fact that patients were informed that new treatment methods were being developed gave them hope.
  • Our subsidiary in the U.S. sponsors and participates in various charity and walking events to raise awareness/recognition of ALS.
    We also support educational activities (ALS educational symposiums, programs for caregivers, support for medical professionals and care services, etc.) In 2019, we also launched an art program for family caregivers of ALS patients.
    ALSO US™" https://www.alsousart.com/
  • Mitsubishi Tanabe Pharma Group holds various seminars for patients with intractable diseases and contributes to medical care by responding to diversifying medical needs, proposing the best treatment for each patient's condition, and working on information provision activities for the proper use and dissemination of pharmaceutical products.
  • The Mitsubishi Tanabe Pharma Group provides health support information on intractable diseases through its website.
    https://www.mt-pharma.co.jp/general/
    The Mitsubishi Tanabe Pharma Group's health support website provides information on disease symptoms and treatment, as well as useful information to support the daily lives of patients and their families, in an easy-to-understand manner with illustrations, in order to inform as many people as possible about diseases and the importance of treatment.
    Health Support Site Introduction Leaflet
    h ttps:// www.mt-pharma.co.jp/sustainability/social/pdf/leaflet.pdf
  • Mitsubishi Tanabe Pharma Group holds work seminars (with social events) for inflammatory bowel disease (IBD) patients jointly with G-Care (now Gutte).
    https://www.mt-pharma.co.jp/news/2021/info210901.html
    The "Troubles of Employment" https://www.remicare.jp/cd/cafenote/
Chugai Pharmaceutical Co.
  • We co-sponsor Rare Disease Day in Japan every year to promote understanding and support for rare and intractable diseases. The URL of our intractable and rare disease website is listed in the "List of Materials Provided by Supporting Companies" to promote the provision of information to patients.
  • To raise awareness of Neuromyelitis Optica Spectrum Disorder (NMOSD) Day (10.24), we co-host an awareness event with the Japan Neuromyelitis Optica Patients Association (NPO) every October.
  • NMOSD-ONLINE, an information website for neuromyelitis optica patients, is also available at https://nmosd-online.jp/
  • In collaboration with fashion and travel magazines, NMOSD-ONLINE has published articles on hair care/hair arranging and travel guides to raise awareness of neuromyelitis optica (NMOSD) and to encourage patients to take a positive approach to treatment. https://nmosd-online. jp/support/
  • Food support content for patients with spinal muscular atrophy and their families [Travel Food to Enjoy at Home] is now available on the web.  https://with-your-sma.jp/food/
  • With your SMA, an information site for patients with spinal muscular atrophy, is also available on the web at https://with-your-sma.jp/
  • A disease awareness website for the general public about paroxysmal nocturnal hemoglobinuria (PNH), "Oshiete PNH no koto" (Tell us about PNH), was created in collaboration with a patient group and is now available on the web. https://www. chugai-pharm.co.jp/ptn/oshiete-pnh/
  • We support "World Hemophilia Day" promoted by the World Federation of Hemophilia Associations and conduct disease awareness activities both inside and outside the company.
    In 2023, we will (1) hold an in-house lecture by a patient organization on World Hemophilia Day (WHD) (for employees), (2) hold an experimental class for hemophilia-affected children in grades 3 to 6 of elementary school, and (3) hold a public lecture: I see! Hemophilia Workshop 2 was held. https://smile-on.jp/useful/event/report_202306.html
Pfizer Inc.
  • Every year, Pfizer conducts internal and external awareness efforts to coincide with the last day of February, which is World Rare and Refractory Disease Day (RDD).
    In 2024, Pfizer created and distributed a collaborative video with a YouTuber who is popular for his positive and humorous content despite being born with various rare diseases. In addition, Pfizer sponsored an advertisement project for two major newspapers that was published on the day of the RDD on February 29.
    Reference link (collaboration video): https: //www.youtube.com/watch?v=BJmq3eGH8wY
  • In addition to the above, on each disease awareness day in Japan and around the world, we collaborate with patient groups or conduct disease awareness activities for the general public (e.g., by sending out relevant information via official SNS (Instagram, X)). For example, on World IBD Day on May 19, 2024, Pfizer collaborated with a patient group that planned an event to light up Osaka Castle to announce the event, and used photos of Osaka Castle lit up to raise awareness of the disease.
  • In 2023, Pfizer has begun disseminating information externally with the aim of increasing appropriate understanding and awareness of gene therapy. Press seminars were held for the media, leading to reports based on appropriate understanding by reporters, while awareness-raising articles were posted and posted on external websites and official social networking sites for the general public.
  • Pfizer provides disease awareness websites to ensure that correct and easy-to-understand information reaches patients with intractable and rare diseases and the general public. For example, the "Growth Counseling Office for Children's Short Stature" includes a "Short Stature Check" and a "Medical Institution Search Page" so that parents who are concerned about their child's short stature can search for a doctor specializing in short stature. In addition, since public health nurses and school nurses are also involved in the growth of children, we have also prepared a website for them to order disease awareness booklets and materials from this page and use them for disease awareness in their respective regions.
    Related sites:
    Growth Counseling Center for Children's Short Stature," an information site on short stature, growth disorders, and growth hormone therapy: https://ghw.pfizer.co.jp/
    For health nurses, nursery school teachers, and school nurses who support growth", a website for health nurses, nursery school teachers, and school nurses about growth disorders: https: //ghw.pfizer.co.jp/comedical/
    Adult growth hormone deficiency and hypopituitarism information site "Adult growth hormone deficiency" https://ghw.pfizer.co.jp/adult/index.html
    Hemophilia Life, an information site for hemophilia-related information to support the lives of hemophiliacs: https://hemophilia-life.jp/
    TTRFAP.jp, an information site for transthyretin-type familial amyloid polyneuropathy: https://www.ttrfap.jp/
    ATTRCM.jp", an information site for transthyretin-type cardiac amyloidosis (ATTR-CM): https://www.attrcm.jp/
    UC Tomorrow - Let's Talk More About Ulcerative Colitis," an information site for ulcerative colitis: https: //www.uctomorrow.jp/

Share this page

TOP